STOK
Stoke Therapeutics, Inc. · Healthcare
CFO Thomas Leggett sold $147K of Stoke Therapeutics, Inc.
Sold$147,145
$32.14Price
4,578Shares
−31%Stake
What STOK did after the filing
- The stock from Thu, Mar 19 close, $33.19
- −0.3%
- S&P 500, same days
- +9.2%
Measured over 30 trading days, to the May 1 close.
Traded Tue, Mar 17. Filed Thu, Mar 19, 2:00 PM ET, during the session. Returns use the Mar 19 close and the May 1 close. Not investment advice.